Metabolomic biomarkers of polycystic ovary syndrome related-obesity: a review of the literature

Romanian Journal of Laboratory Medicine

Cernea Simona¹  Farcas Anca Daniela²  Georgescu Carmen Emanuela³  Vonica Camelia Larisa⁴  Muresan Andrada Alina⁴  Roman Gabriela⁴  Fodor Adriana⁴ 

[1] Faculty of Medicine/Department M4, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of TarguMures, Targu Mures, Romania;“Iuliu Hatieganu” University of Medicine and Pharmacy, Department of Cardiology and Internal Medicine I, Cluj-Napoca, Romania;”Iuliu Hatieganu” University of Medicine and Pharmacy, 6th Department of Medical specialities Endocrinology, Cluj-Napoca, Romania;”Iuliu Hatieganu” University of Medicine and Pharmacy, 6th Department of Medical specialities, Diabetes and Nutrition Diseases, Cluj-Napoca, Romania;

关键词: untargeted metabolomics;    polycystic ovary syndrome;    obesity;    biomarkers;    targeted metabolomics;   

DOI  :  10.2478/rrlm-2020-0017

来源: DOAJ

【 摘 要 】

Background and objectives: Polycystic ovary syndrome (PCOS) displays a phenotype-dependent cardio-metabolic risk. By performing a systematic search of the literature, we aimed to summarize metabolomic signatures associated with obesity in PCOS women.

【 授权许可】

Unknown